Join Viant CEO Alton Shader as he takes you on a tour of Viant's end-to-end expertise and 'in it for life' culture.
Read white papers, technical tips, how-tos, and success stories of how we've partnered with customers to achieve their goals.
Virtual tour of capabilities to manufacture motion preservation spinal disc implants.
Learn how Viant’s best-in-class 3P deployment can help you boost efficiency, speed time to market, and save costs.
From manufacturing transfers to new product introductions, Viant can help accelerate your time to market.
Looking for a partner for a legacy product manufacturing transfer or a new product introduction? Trust Viant to leverage complex project experience to drive speed to market and program success.
For more than a decade, Viant teams have been leveraging Lean Product Launch techniques to improve product quality, lower cost, and speed time to market. 3P is a tool that has been particularly effective for our customers.
With over 10 years of experience and more than 170,000 spinal disc implants made, trust Viant’s Orthopedic Implant and Coatings Center of Excellence for your motion preservation spinal implant program.
$8 million investment, including new building & FDA-approved vacuum plasma spray (VPS) equipment, enhances in-house coating and single-source orthopedic implant capabilities
New & enhanced capabilities will boost speed to market for high quality, complex medical devices
Virtual tour of our thermoplastic injection molding & assembly facility in Suzhou, China
Virtual tour of our thermoplastic and elastomeric molding & complex assembly facility in Heredia, Costa Rica
Virtual tour of our orthopedic implant and instrument facility in Ft Wayne, Indiana
Virtual tour of our finished goods assembly & packaging facility in Grand Rapids, Michigan
Virtual tour of our molding & assembly facility in Tijuana, Mexico
A leading global animal health company came to Viant for help with the manufacturing transfer of IV sets & accessories.
Successful OEMs recognize their top service providers as development partners instead of transactional suppliers.
A mid-sized medical device company was ready to ramp up production of a complex, single-patient-use endoscopic device, but its initial supplier was unable to meet the volume requirements.
A leading, multinational medical technology company needed to transfer manufacturing of a medical device to free up cleanroom manufacturing space for a new product. The customer was facing an aggressive 12-month time frame for the transfer to avoid interrupting product supply.